Hepatology(Liver, Pancreatic, Gall Bladder)

  • Home
  • Hepatology(Liver, Pancreatic, Gall Bladder)
QUILT-2.025 NANT Neoepitope Yeast Vaccine (YE-NEO-001): Adjuvant Immunotherapy Using a Personalized Neoepitope Yeast-Based Vaccine To Induce T-Cell Responses In Subjects W/ Previously Treated Cancers.

Conditions:   Colorectal Cancer;   Triple Negative Breast Cancer;   Head and Neck Squamous Cell Carcinoma;   Melanoma;   Non Small Cell Lung Cancer;   Pancreatic Cancer;   Liver Cancer;   Hormone Receptor Positive Tumor
Intervention:   Biological: YE-NEO-001
Sponsor:   NantBioScience, Inc.
Not yet recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 15, 2018 / by / in
Regulation of Endogenous Glucose Production by Central KATP Channels

Conditions:   Type 2 Diabetes Mellitus;   Glucose Metabolism Disorders;   Glucose, High Blood
Interventions:   Drug: Diazoxide;   Drug: Nicotinic acid;   Drug: Placebo
Sponsors:   Albert Einstein College of Medicine, Inc.;   National Institutes of Health (NIH);   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 14, 2018 / by / in
Ultrasound-guided Percutaneous Biliary Drainage Versus Endoscopic Ultrasound-guided Biliary Drainage

Condition:   Bile Duct Obstruction, Extrahepatic
Interventions:   Procedure: US-guided percutaneous biliary drainage;   Procedure: EUS-guided biliary drainage
Sponsors:   Theresienkrankenhaus und St. Hedwig-Klinik GmbH;   University Hospital Heidelberg
Not yet recruiting
ClinicalTrials.gov: Gall Bladder | Recruiting, Not yet recruiting, Available Studies | First posted in the last 100 days

June 10, 2018 / by / in
Dietary Factors and Risk of Gallbladder Carcinoma in China

Condition:   Dietary Habits
Intervention:  
Sponsors:   liu yingbin;   First Hospital of Jilin University;   Shanghai Zhongshan Hosiptal;   Bengbu medical college affiliated hospital;   Second Affiliated Hospital of Nanchang University;   The Affiliated Hospital of Inner Mongolia Medical University;   First Affiliated Hospital of Xinjiang Medical University;   The First Affiliated Hospital of Shanxi Medical University;   The affiliated hospital of Jining medical college;   The Affiliated Hospital of Tianjin Medical University;   The first affiliated hospital of Zhongshan university
Recruiting
ClinicalTrials.gov: Gall Bladder | Recruiting, Not yet recruiting, Available Studies | First posted in the last 100 days

June 9, 2018 / by / in
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Conditions:   Childhood Hepatocellular Carcinoma;   Childhood Malignant Liver Neoplasm;   Elevated Alpha-Fetoprotein;   Hepatoblastoma;   SMARCB1 Gene Mutation
Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Drug: Doxorubicin;   Drug: Etoposide;   Drug: Fluorouracil;   Drug: Gemcitabine;   Drug: Irinotecan;   Other: Laboratory Biomarker Analysis;   Drug: Oxaliplatin;   Other: Patient Observation;   Drug: Sorafenib;   Drug: Vincristine Sulfate
Sponsors:   Children’s Oncology Group;   National Cancer Institute (NCI)
Recruiting
ClinicalTrials.gov: Liver | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

June 8, 2018 / by / in